Previous Close | 0.1750 |
Open | 0.1800 |
Bid | 0.1800 x 0 |
Ask | 0.2000 x 0 |
Day's Range | 0.1750 - 0.1800 |
52 Week Range | 0.1500 - 0.2600 |
Volume | |
Avg. Volume | 12,570 |
Market Cap | 40.152M |
Beta (5Y Monthly) | -0.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings Date | Apr 19, 2024 - Apr 21, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
January 18, 2024 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field o...
Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field...
Will present new preclinical data on L-DOS47 in combination with PD1 checkpoint inhibition at the 2023 ...